March 31, 2025
Emerging evidence points to potential benefits of continuous glucose monitoring (CGM) well beyond use as a management tool for people with diabetes who use insulin. Until […]
March 31, 2025
TOPLINE: Echocardiography was associated with survival time and readmission in patients with type 2 diabetes (T2D). Moreover, it was positively correlated with survival time in patients […]
March 28, 2025
The European Medicines Agency (EMA) has concluded a review of the weight loss drug naltrexone/bupropion (Mysimba), which was prompted by concerns about potential long-term cardiovascular risks. […]
March 27, 2025
TOPLINE: In patients with type 2 diabetes (T2D) and albuminuria, compared with placebo, dapagliflozin reduced the urine albumin-to-creatinine ratio (UACR) by 15.1%, with a considerable variation […]
March 27, 2025
TOPLINE: A significant association was found between asthma and type 2 diabetes (T2D), even after adjusting for body mass index (BMI). Additionally, individuals with a sibling […]
March 26, 2025
Investigators are searching for a way forward after two long-term diabetes programs were terminated following the cancellation of their National Institutes of Health (NIH) funding, the […]
March 25, 2025
TOPLINE: Waist circumference was shown to be a stronger marker than body mass index (BMI) for the risk of developing obesity-related cancers in men but not […]
March 25, 2025
Diabetes treatment has advanced since several diabetes organizations united to recommend a “time in range” target of 70-180 mg/dL for glucose levels derived from continuous glucose […]
March 25, 2025
TOPLINE: A meta-analysis of randomized controlled trials involving over 59,000 patients with diabetes or obesity showed no statistically significant difference in the risk for suicide between […]